Although the results achieved by schett in patients with SLE were unprecedented, <a href=https://metspace.com/luciano-arrambide-rosales-for-metspacer-spotlight/>https://metspace.com/luciano-arrambide-rosales-for-metspacer-spotlight/</a> has huge shortcomings in the use of standard car-T cell therapy in patients with autoimmune diseases.